Clinical Trial Update: Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial [Phase 3]

View source ↗

Summary

Phase 3 STArT trial evaluating arginine therapy for sickle cell disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Claudia R. Morris | Conditions: Sickle Cell Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-07-30